Dr. Joshua Israel Keil, D.O. Optometrist Medicare: Not Enrolled in Medicare Practice Location: Building 2104 Massey Avenue, Nas Mayport, FL 32228 Phone: 904-270-4328 |
News Archive
AVEO Oncology and Astellas Pharma Inc. today announced that AVEO has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for tivozanib in patients with advanced renal cell carcinoma (RCC).
nSpire Health, a leading global manufacturer of respiratory diagnostic products and services, announced today clinical trial research services awards of over $9 million in August. The trials awarded by prominent pharmaceutical companies include the company's eSP™ core lab services, gold standard KoKo® spirometry, and new patent pending PiKoLogic® electronic patient reported outcomes (ePRO) solution.
An international team of medical experts led by a Virginia Commonwealth University researcher has established the first clinical guidelines to help improve the diagnosis and treatment of people with normal pressure hydrocephalus, a debilitating condition in the brain that often goes undiagnosed or is misdiagnosed as Alzheimer's or Parkinson's disease.
More than $11 million over three years will be used to support research exploring the use of social media to advance the scientific understanding, prevention, and treatment of substance use and addiction.
› Verified 1 days ago